0000885590-15-000005.txt : 20150107
0000885590-15-000005.hdr.sgml : 20150107
20150107173850
ACCESSION NUMBER: 0000885590-15-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150105
FILED AS OF DATE: 20150107
DATE AS OF CHANGE: 20150107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schiller Howard Bradley
CENTRAL INDEX KEY: 0001536053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 15514371
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
CITY: LAVAL
STATE: A8
ZIP: H7L 4A8
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2015-01-05
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001536053
Schiller Howard Bradley
2150 ST. ELZEAR BLVD. WEST
LAVAL
A8
H7L 4A8
QUEBEC, CANADA
0
1
0
0
EVP, Chief Financial Officer
Common Stock, no par value
2015-01-05
4
M
0
45000
0
A
318714
D
Common Stock, no par value
2015-01-05
4
F
0
23600
0
D
295114
D
Restricted Share Units
2015-01-05
4
M
0
45000
0
D
Common Stock
22500
22500
D
This represents the number of units vested on the performance-based RSUs ("PSUs") that were previously reported on the original Form 4. The initial grant was reported to vest based on total shareholder return (TSR) between a price of $42.70 starting on December 1, 2011 and the average stock price for the 20 trading days starting on each measurement dates: 25% on September 1, 2014, 50% on December 1, 2014 and 25% on March 1, 2015. Unit vesting is contingent on TSR performance between 15% and 45% into between one and three shares of common stock, respectively, with early vesting possible at higher TSR levels.
This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Performance Share Units.
Represents the maximum number of Common Shares that may be issued under the RSU award. See note 1.
by: Nicholas Zanoni for Howard Schiller
2015-01-07